Leptomeningeal metastases (LM) are the multifocal seeding of the leptomeninges by malignant carcinomatous cells [1]. Malignant cells can reach the meninges by several different pathways: haematogenous spread via arterial or venous circulation, perivascular lymphatic spread, endoneural and perineural spread, direct spread from metastases located in the brain or bone in proximity to the subarachnoid or ventricular spaces, and spread from choroid plexus and subependymal metastases. Two types of leptomeningeal tumor spread can be distinguished: the first with free-floating non-adherent cancer cells (diffuse type); and the second characterized by contrast-enhanced leptomeningeal nodules (nodular type).
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2hzkn45
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Blinatumomab is a bispecific T-cell engaging αCD19 antibody used in refractory or relapsed B-cell precursor acute lymphoblastic l...
-
About 540 million years ago a group of jellyfish washed ashore, died and fossilised – preserving evidence of the earliest example of an anim...
-
The pursuit for clarity in diagnostic and treatment pathways for the complex, chronic condition of myalgic encephalomyelitis/chronic fatigue...
-
Abstract Objective To study clinical profile and outcome in patients with methemoglobinemia following exposure to toxic colors during Ho...
-
Acquired Vascular Tumors of the Head and Neck. Otolaryngol Clin North Am. 2017 Oct 26;: Authors: Persky M, Tran T Abstract Vascular...
-
Background. Sevoflurane is rarely used for the treatment of status asthmaticus. We report a case of sevoflurane hepatotoxicity in pregnancy ...
-
To survive in its sand fly vector, the trypanosomatid protozoan parasite Leishmania first attaches to the midgut to avoid excretion, but eve...
-
Publication date: Available online 4 May 2017 Source: Journal of Dairy Science Author(s): V. Bonfatti, D. Vicario, A. Lugo, P. Carnier T...
-
Approximately 25% of non–small cell lung cancer (NSCLC) patients have KRAS mutations, and no effective therapeutic strategy exists for thes...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου